Theonie Anastassiadis

Founder en Flagship Labs 89, Inc. .

Health Technology

Finance

Consumer Services

Perfil

Ms. Theonie Anastassiadis is a Chief Innovation Officer at Alltrna, a President at Prologue Medicines, Inc. and a Principal at Flagship Pioneering.
She received her undergraduate degree from Haverford College.

Cargos activos de Theonie Anastassiadis

Empresas	Cargo	Inicio
Flagship Pioneering Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.	Private Equity Analyst	-
Alltrna Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.	Founder	-
Flagship Labs 89, Inc.	Founder	-

Todos los cargos activos de Theonie Anastassiadis

Formación de Theonie Anastassiadis.

Haverford College

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Theonie Anastassiadis.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Flagship Pioneering Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.	Finance
Alltrna Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.	Health Technology
Flagship Labs 89, Inc.	Health Technology

Ver las conexiones de la empresa